A Double-blind, Placebo-controlled, Randomized Study on the Safety and Efficacy of Apremilast in Patients With Moderate to Severe Plaque Psoriasis Involving Palms and/or Soles
Phase of Trial: Phase IV
Latest Information Update: 09 Feb 2017
At a glance
- Drugs Apremilast (Primary)
- Indications Plaque psoriasis
- Focus Therapeutic Use
- Sponsors Innovaderm Research
- 06 Feb 2017 Status changed from active, no longer recruiting to completed.
- 23 Feb 2016 Planned End Date changed from 1 Jan 2017 to 1 Nov 2016 as reported by ClinicalTrials.gov record.
- 23 Feb 2016 Planned primary completion date changed from 1 Mar 2016 to 1 Sep 2016 as reported by ClinicalTrials.gov record.